Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAI Arrive AI	$6.00 -6.3%	$8.80	$4.61 ▼ $40.00	$198.14M	N/A	246,190 shs	166,487 shs
FORA Forian	$2.00 +3.6%	$2.00	$1.85 ▼ $4.03	$62.40M	1	19,301 shs	25,010 shs
MIMI Mint Incorporation	$7.64 -4.1%	$7.39	$3.36 ▼ $9.99	$173.81M	N/A	1.04 million shs	280,665 shs
OABI OmniAb	$2.01 +0.5%	$1.88	$1.22 ▼ $4.87	$245.49M	0.16	495,553 shs	339,558 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAI Arrive AI	-6.25%	-15.13%	-35.90%	+599,999,900.00%	+599,999,900.00%
FORA Forian	+3.63%	+5.26%	+2.04%	-6.98%	-19.03%
MIMI Mint Incorporation	-4.14%	-23.14%	+11.37%	+52.80%	+763,999,900.00%
OABI OmniAb	+0.50%	+2.03%	+1.52%	+27.22%	-51.09%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARAI Arrive AI	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FORA Forian	2.1739 of 5 stars	3.5	2.0	0.0	0.0	2.7	1.7	0.0
MIMI Mint Incorporation	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	3.0504 of 5 stars	3.5	2.0	0.0	0.0	3.3	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARAI Arrive AI	0.00	N/A	N/A	N/A
FORA Forian	3.00	Buy	$5.00	150.00% Upside
MIMI Mint Incorporation	0.00	N/A	N/A	N/A
OABI OmniAb	3.00	Buy	$6.67	231.67% Upside

Current Analyst Ratings Breakdown

Latest FORA, OABI, ARAI, and MIMI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/7/2025	OABI OmniAb	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$4.00 ➝ $3.00

(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARAI Arrive AI	N/A	N/A	N/A	N/A	N/A	N/A
FORA Forian	$22.33M	2.79	N/A	N/A	N/A	∞
MIMI Mint Incorporation	N/A	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	$26.39M	9.30	N/A	N/A	$2.15 per share	0.93

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARAI Arrive AI	-$4.54M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FORA Forian	N/A	-$0.09	N/A	∞	N/A	N/A	N/A	N/A	N/A
MIMI Mint Incorporation	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	-$62.03M	-$0.60	N/A	N/A	N/A	-275.83%	-22.79%	-20.18%	N/A

Latest FORA, OABI, ARAI, and MIMI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	ARAI Arrive AI	N/A	-$0.05	N/A	-$0.15	N/A	$0.09 million
8/6/2025	Q2 2025	OABI OmniAb	-$0.14	-$0.15	-$0.01	-$0.15	$5.33 million	$3.90 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARAI Arrive AI	N/A	N/A	N/A	N/A	N/A
FORA Forian	N/A	N/A	N/A	N/A	N/A
MIMI Mint Incorporation	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARAI Arrive AI	N/A	3.80	3.80
FORA Forian	N/A	N/A	N/A
MIMI Mint Incorporation	N/A	N/A	N/A
OABI OmniAb	N/A	3.77	3.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARAI Arrive AI	N/A
FORA Forian	19.25%
MIMI Mint Incorporation	N/A
OABI OmniAb	72.08%

Insider Ownership

Company	Insider Ownership
ARAI Arrive AI	N/A
FORA Forian	34.30%
MIMI Mint Incorporation	N/A
OABI OmniAb	8.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARAI Arrive AI	7	33.02 million	N/A	N/A
FORA Forian	140	31.20 million	N/A	Optionable
MIMI Mint Incorporation	15	22.75 million	N/A	N/A
OABI OmniAb	7	122.14 million	111.63 million	Optionable

FORA, OABI, ARAI, and MIMI Headlines

Recent News About These Companies

OmniAb (OABI) Gets a Buy from Craig-Hallum

August 12, 2025 | theglobeandmail.com

OmniAb (NASDAQ:OABI) Price Target Lowered to $3.00 at Royal Bank Of Canada

August 8, 2025 | marketbeat.com

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

August 7, 2025 | seekingalpha.com

OmniAb Inc (OABI) Q2 2025 Earnings Report Preview: What To Expect

August 6, 2025 | finance.yahoo.com

OmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue Estimates

August 6, 2025 | zacks.com

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

August 6, 2025 | businesswire.com

OmniAb (OABI) Projected to Post Earnings on Wednesday

July 31, 2025 | marketbeat.com

Private Management Group Inc. Has $6.07 Million Position in OmniAb, Inc. (NASDAQ:OABI)

July 27, 2025 | marketbeat.com

OmniAb to Report Second Quarter 2025 Financial Results on August 6

July 16, 2025 | businesswire.com

Positive week for OmniAb, Inc. (NASDAQ:OABI) institutional investors who lost 47% over the past year

July 4, 2025 | finance.yahoo.com

Chairman of OmniAb Picks Up 3.0% More Stock

May 19, 2025 | uk.finance.yahoo.com

OmniAb, Inc. (NASDAQ:OABI) Director Steven Love Purchases 25,000 Shares

May 15, 2025 | insidertrades.com

Insider Buying: OmniAb, Inc. (NASDAQ:OABI) Director Buys 65,000 Shares of Stock

May 14, 2025 | insidertrades.com

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025 | businesswire.com

Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030?

May 10, 2025 | insidermonkey.com

OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript

May 10, 2025 | msn.com

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025 | seekingalpha.com

OmniAb Introduces the xPloration® Partner Access Program

May 9, 2025 | tmcnet.com

OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates

May 8, 2025 | zacks.com

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025 | businesswire.com

VERAXA Biotech AG and OmniAb, Inc. Announce Co-Discovery Alliance for Novel Bispecific Antibody Drug Conjugate Program Targeting Solid Tumors

May 5, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

FORA, OABI, ARAI, and MIMI Company Descriptions

Arrive AI NASDAQ:ARAI

$6.00 -0.40 (-6.25%)

As of 08/15/2025 04:00 PM Eastern

We were incorporated on April 30, 2020, in the State of Delaware under the name of Dronedek Corporation. The Company changed its name to Arrive Technology Inc. on July 27, 2023. The Company changed its name to Arrive AI Inc. on September 30, 2024. We are a developmental technology company with a focus on designing and implementing a commercially viable smart mailbox and platform system for smart, secure, and seamless exchange of packages, goods, supplies, food, and medications between people, through the use of robots, and drones. We have not started conducting commercial operations and we had no revenues for fiscal years 2022, 2023 or 2024. Arrive executed an exclusive patent license agreement on May 26, 2020 with its CEO, Mr. O’Toole and amended in December 2024 and March 2025, whereby Mr. O’Toole granted Arrive rights to use, sell, manufacture and otherwise commercialize certain technologies relating to secured drone delivery ALM mailboxes in exchange for license fees. Such technologies helped jumpstart our business operations and will continue to play such a critical role in our growth that we became heavily reliant on the right to use them. Our corporate address is in Fishers, Indiana.

Forian NASDAQ:FORA

$2.00 +0.07 (+3.63%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$2.00 0.00 (0.00%)

As of 08/15/2025 04:45 PM Eastern

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

Mint Incorporation NASDAQ:MIMI

$7.64 -0.33 (-4.14%)

As of 08/15/2025 04:00 PM Eastern

Mint, Inc. Ltd. is a company that engages in the provision of interior design and fit works. The company offers design services including layout plans and sketches presented in the form of 3d technical drawing and design and fit out services. The company was founded in 2018 and is headquartered in Hong Kong.

OmniAb NASDAQ:OABI

$2.01 +0.01 (+0.50%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$1.97 -0.04 (-1.79%)

As of 08/15/2025 04:59 PM Eastern

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time